Send feedback

MYO7A p.Arg1743Trp

c.5227C>T · rs111033287 · VCV43278

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 13 submitters
AlphaMissense
likely benign
0.3111 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.31%, nfe)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
4
Usher syndrome type 1

Computational evidence

Protein change
AlphaMissense0.3111likely benign
REVEL0.412indeterminate
SaProtLLR -3.48tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.27GERP 1.8, phastCons 0.92
Regional constrainto/e 0.95unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic
Overall
CADD24.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.31% European (non-Finnish) · 3,561/1,147,358 alleles
Filtering AF 0.302% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.298%
Overall 0.257% 3,978/1,549,698 alleles · rare exomes 3,651/1,397,344 · genomes 327/152,354 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.339% 295
European (non-Finnish)grpmax 0.31% 322
Finnishnot grpmax-eligible 0.297% 336
Remaining individualsnot grpmax-eligible 0.138% 722
Admixed American 0.0568% 1,762
African / African-American 0.0383% 2,612
Middle Eastern 0.0228% 4,388
East Asian 0.00488% 20,488
South Asian 0.00119% 84,006

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7A
Protein
p.Arg1743Trp
Coding
c.5227C>T
MANE Select
NM_000260
dbSNP
rs111033287
Type
single nucleotide variant
Location
chr11:77203118 (GRCh38)
Gene constraint
LOEUF 0.995 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 77.73 · 1 PDB
Residue 1743
a UniProt-annotated variant site (in ush1b)
Full MYO7A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Usher syndrome type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: autosomal recessive nonsyndromic hearing loss 2autosomal dominant nonsyndromic hearing loss 11Usher syndrome type 1B

For Usher syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Childhood, Infancy, Neonatal
Prevalence
1-9 / 100 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-arg1743trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown